Location History:
- Morristown, NJ (US) (2010 - 2012)
- Somerset, NJ (US) (2010 - 2022)
- Hightstown, NJ (US) (2010 - 2022)
Company Filing History:
9 out of 3,685 
1 out of 3 
1 out of 8 Years Active: 2010-2022
Title: The Inventor Spotlight: David Kenneth Leahy
Introduction:
David Kenneth Leahy, a prolific inventor hailing from Hightstown, NJ, boasts an impressive portfolio of 11 patents. With a focus on groundbreaking advancements in antiviral agents, his latest patents showcase his innovative spirit and commitment to improving healthcare.
Latest Patents:
One of Leahy's recent inventions includes the development of salts of prodrugs of piperazine and substituted piperidine antiviral agents. These compounds demonstrate potential in treating HIV infection, opening new avenues in the field of antiviral therapies. Additionally, he has introduced a novel process for the preparation of N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, showcasing his expertise in pharmaceutical synthesis.
Career Highlights:
Leahy has left a significant mark in the pharmaceutical industry, with notable stints at Bristol-Myers Squibb Company. His contributions to drug development and process improvement have earned him recognition among his peers and the scientific community at large.
Collaborations:
Throughout his career, Leahy has collaborated with esteemed professionals such as Chung-Pin H Chen and Yasutsugu Ueda. These collaborations have led to the exchange of ideas, fostering innovation and driving progress in the pharmaceutical field.
Conclusion:
In conclusion, David Kenneth Leahy's dedication to innovation and his remarkable contributions to the realm of antiviral agents underscore his status as a visionary inventor. His patented inventions stand as a testament to his ingenuity and commitment to advancing healthcare solutions.